Shigeo Nakamura
Representative Executive Officer, President, CEO
Replay available
Ajinomoto Co Inc (OTC: AJINF) Q4 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Representative Executive Officer, President, CEO
Analyst, Bernstein
Good evening, everyone. Despite your busy schedule, thank you very much for your participation to the FY twenty twenty '5 final result briefing of Ajinomoto. I'm Go to of IR office playing as a moderator. First of all, I would like to introduce today's participants. New executive structure from April of which eight members are here with us today. Representative Executive Officer, President, CEO, Nakamura Representative Executive Officer, Executive Vice President, Kaho Representative Executive Officer and Senior Vice President, General Manager, Food Products Division, Sakakura Executive Officer and Vice President, General Manager, BioPharm Chemicals Division, Arashida Executive Officer and Vice President in charge of Finance, Mizutani Executive Officer and Vice President, CTO in charge of Quality Assurance, Sumuriba Executive Officer, Supervision of Frozen Foods Business, Komura Executive Officer in charge of IR, Kaji. Today, CEO Nakamura will make presentation on FY 2026 Forecasts and Initiative for Enhancing Corporate Value followed by Q and A. The overall briefing is scheduled an hour and thirty minutes. Today's material could be found on IR page of Ajinomoto's website. Please refer to the material. We will be recording today's contents, including the Q and A session and at a later date will be uploaded on the IR website. I would like to have your understanding. So we would like to start. Nakamura san, please. Hello, my name is Shigeo Nakamura. Thank you very much for attending today. Now I would like to make a presentation. Today, I would like to discuss four major points. In fiscal twenty twenty five, as in the previous fiscal year, we set new records for both sales and business profit. Business profit continued double digit growth. In Healthcare and others, the ...